Literature DB >> 2129412

Use of a simplified dilute Russell's viper venom time (DRVVT) confirms heterogeneity among 'lupus anticoagulants'.

T Exner1, G Papadopoulos, J Koutts.   

Abstract

A simplified dilute Russell's viper venom time (DRVVT) test--in which the venom, trace phospholipid and calcium were combined into a single reagent--was evaluated for the detection of lupus anticoagulants (LA) in 28 plasma samples containing non-specific circulating anticoagulants. In agreement with previous studies, the DRVVT was found to be insensitive to defects in contact and haemophilic factors and was only marginally affected by antibodies directed against factor VIII. Thus, the use of a DRVVT test in investigations of anticoagulants reduces the risk of confusing a haemorrhagic inhibitor of factor VIII with a non-haemorrhagic LA. In comparisons of sensitivity against activated partial thromboplastin time tests (APTT-Actin FSL and Organon-Teknika reagents) the simplified DRVVT was prolonged slightly more than the APTT in most of the test plasmas containing various non-specific circulating anticoagulants. Three anticoagulants affecting APTTs more than the DRVVT were found to be associated with anticardiolipin IgMs. APTT-prolonging anticoagulants, whether prolonging DRVVT tests or not, showed similar 'correction' of their APTTs by the addition of platelets or phospholipid. Thus, phospholipid-dependent or LA show heterogeneity. Those affecting only the APTT and not DRVVT should perhaps be classified differently.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2129412     DOI: 10.1097/00001721-199008000-00002

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  6 in total

1.  Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosus.

Authors:  D Ferro; M Saliola; C Quintarelli; G Valesini; S Basili; A M Grandilli; M S Bonavita; F Violi
Journal:  J Clin Pathol       Date:  1992-04       Impact factor: 3.411

2.  Clinical usefulness of the dilute Russell viper venom time test for patients taking warfarin.

Authors:  Kazunori Kanouchi; Hiroto Narimatsu; Okio Ohnuma; Keita Morikane; Akira Fukao
Journal:  Int J Hematol       Date:  2017-04-07       Impact factor: 2.490

3.  Significance of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays.

Authors:  Akito Tsutsumi; Taichi Hayashi; Yusuke Chino; Mizuko Mamura; Daisuke Goto; Isao Matsumoto; Satoshi Ito; Takayuki Sumida
Journal:  Mod Rheumatol       Date:  2006       Impact factor: 3.023

4.  Anti-Phosphatidylserine/Prothrombin Antibodies Are Associated with Adverse Pregnancy Outcomes.

Authors:  Polona Žigon; Katja Perdan Pirkmajer; Matija Tomšič; Tanja Kveder; Borut Božič; Snežna Sodin Šemrl; Saša Čučnik; Aleš Ambrožič
Journal:  J Immunol Res       Date:  2015-05-20       Impact factor: 4.818

5.  Anti-phospholipid antibodies in patients undergoing total joint replacement surgery.

Authors:  Melissa Simpson; Michael J Sanfelippo; Adedayo A Onitilo; James K Burmester; William Hocking; Steven H Yale; Joseph J Mazza
Journal:  Thrombosis       Date:  2012-10-31

6.  Detection of antiphosphatidylserine/prothrombin antibodies and their potential diagnostic value.

Authors:  Polona Žigon; Saša Čučnik; Aleš Ambrožič; Tanja Kveder; Snežna Sodin Šemrl; Blaž Rozman; Borut Božič
Journal:  Clin Dev Immunol       Date:  2013-09-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.